| Authors: |
Duke-Cohan JS; Laboratory of Immunobiology, Dana-Farber Cancer Institute, Boston, MA, USA. jonathan_duke-cohan@dfci.harvard.edu.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. jonathan_duke-cohan@dfci.harvard.edu.; Department of Medicine, Harvard Medical School, Boston, MA, USA. jonathan_duke-cohan@dfci.harvard.edu., Akitsu A; Laboratory of Immunobiology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA., Mallis RJ; Laboratory of Immunobiology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Dermatology, Harvard Medical School, Boston, MA, USA., Messier CM; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, MA, USA., Lizotte PH; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, MA, USA., Aster JC; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Hwang W; Department of Biomedical Engineering, Texas A&M University, College Station, TX, USA.; Department of Materials Science and Engineering, Texas A&M University, College Station, TX, USA.; Department of Physics and Astronomy, Texas A&M University, College Station, TX, USA., Lang MJ; Department of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN, USA.; Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN, USA., Reinherz EL; Laboratory of Immunobiology, Dana-Farber Cancer Institute, Boston, MA, USA. ellis_reinherz@dfci.harvard.edu.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. ellis_reinherz@dfci.harvard.edu.; Department of Medicine, Harvard Medical School, Boston, MA, USA. ellis_reinherz@dfci.harvard.edu. |
